• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

1990 - 2010年美国国防部军事医疗系统中被诊断为前列腺癌的男性的种族与总生存率

Race and overall survival in men diagnosed with prostate cancer in the Department of Defense Military Health System, 1990-2010.

作者信息

Alexander Melannie, Zhu Kangmin, Cullen Jennifer, Byrne Celia, Brown Derek, Shao Stephanie, Rusiecki Jennifer

机构信息

Department of Preventive Medicine and Biostatistics, Uniformed Services University of the Health Sciences, 4301 Jones Bridge Road, Bethesda, MD, 20814, USA.

John P. Murtha Cancer Center, Walter Reed National Military Medical Center, Bethesda, MD, USA.

出版信息

Cancer Causes Control. 2019 Jun;30(6):627-635. doi: 10.1007/s10552-019-01163-5. Epub 2019 Apr 17.

DOI:10.1007/s10552-019-01163-5
PMID:30997591
Abstract

BACKGROUND

In the U.S. general population, black men experience poorer survival after prostate cancer (CaP) diagnosis compared to white men, and findings may be impacted by unequal access to healthcare. The objective of the study is to investigate racial differences in overall survival (OS) among Department of Defense beneficiaries diagnosed with CaP.

METHODS

A retrospective cohort study was conducted utilizing the Automated Central Tumor Registry within the Military Healthcare System, a system designed to provide equal access. Men diagnosed with primary prostate adenocarcinomas between 1990 and 2010 [n = 18,484; 24% Non-Hispanic black (NHB), 76% Non-Hispanic white (NHW)] were followed through 2013 for vital status. Unadjusted Kaplan-Meier estimation curves and multivariable Cox proportional hazards (PH) regression models were used to examine racial differences in OS.

RESULTS

Age-specific Kaplan-Meier analyses showed equivalent OS for NHW and NHB men in all age groups, except for 75+, where NHB had poorer OS (p = 0.0048). Multivariable Cox PH models revealed no significant differences in OS for race (HR 1.02; 95% CI 0.95-1.08), except in men aged ≥ 75 years, where NHB men had poorer OS (HR 1.27; 95% CI 1.08-1.49).

CONCLUSIONS

Findings suggest that in a healthcare system designed for equal access, disparities in OS among men diagnosed with CaP may not exist.

摘要

背景

在美国普通人群中,前列腺癌(CaP)诊断后黑人男性的生存率低于白人男性,而研究结果可能受到医疗保健获取不平等的影响。本研究的目的是调查国防部受益人群中被诊断为CaP的患者在总生存期(OS)方面的种族差异。

方法

利用军事医疗系统中的自动化中央肿瘤登记处进行了一项回顾性队列研究,该系统旨在提供平等的医疗服务。对1990年至2010年间被诊断为原发性前列腺腺癌的男性进行随访,直至2013年以了解其生命状态[n = 18484;24%为非西班牙裔黑人(NHB),76%为非西班牙裔白人(NHW)]。使用未调整的Kaplan-Meier估计曲线和多变量Cox比例风险(PH)回归模型来检验OS方面的种族差异。

结果

特定年龄的Kaplan-Meier分析显示,除了75岁及以上年龄组外,所有年龄组的NHW和NHB男性的OS相当,在75岁及以上年龄组中,NHB的OS较差(p = 0.0048)。多变量Cox PH模型显示,种族在OS方面无显著差异(HR 1.02;95% CI 0.95 - 1.08),但在年龄≥75岁的男性中,NHB男性的OS较差(HR 1.27;95% CI 1.08 - 1.49)。

结论

研究结果表明,在一个旨在提供平等医疗服务的医疗系统中,被诊断为CaP的男性在OS方面可能不存在差异。

相似文献

1
Race and overall survival in men diagnosed with prostate cancer in the Department of Defense Military Health System, 1990-2010.1990 - 2010年美国国防部军事医疗系统中被诊断为前列腺癌的男性的种族与总生存率
Cancer Causes Control. 2019 Jun;30(6):627-635. doi: 10.1007/s10552-019-01163-5. Epub 2019 Apr 17.
2
Racial Differences in Time to Breast Cancer Surgery and Overall Survival in the US Military Health System.美国军事医疗体系中种族差异对乳腺癌手术时间和整体存活率的影响。
JAMA Surg. 2019 Mar 1;154(3):e185113. doi: 10.1001/jamasurg.2018.5113. Epub 2019 Mar 20.
3
Racial disparities in survival among women with endometrial cancer in an equal access system.在公平获得医疗系统中,子宫内膜癌患者的生存存在种族差异。
Gynecol Oncol. 2021 Oct;163(1):125-129. doi: 10.1016/j.ygyno.2021.07.022. Epub 2021 Jul 27.
4
Patient Characteristics at Prostate Cancer Diagnosis in Different Races at an Academic Center Serving a Diverse Population.在服务于不同人群的学术中心,不同种族的前列腺癌患者的特征。
Clin Genitourin Cancer. 2019 Apr;17(2):139-144. doi: 10.1016/j.clgc.2018.12.003. Epub 2018 Dec 13.
5
Effect of type of definitive treatment on race-based differences in prostate cancer-specific survival.根治性治疗方式对基于种族的前列腺癌特异性生存差异的影响。
Prostate. 2023 Aug;83(11):1099-1111. doi: 10.1002/pros.24552. Epub 2023 May 7.
6
Racial disparities in colorectal cancer outcomes and access to care: a multi-cohort analysis.结直肠癌结局和获得医疗服务的种族差异:多队列分析。
Front Public Health. 2024 Jun 19;12:1414361. doi: 10.3389/fpubh.2024.1414361. eCollection 2024.
7
Widening disparity in survival between white and African-American patients with breast carcinoma treated in the U. S. Department of Defense Healthcare system.在美国国防部医疗系统接受治疗的白人乳腺癌患者和非裔美国乳腺癌患者之间,生存率差距不断扩大。
Cancer. 2003 Sep 1;98(5):894-9. doi: 10.1002/cncr.11604.
8
Race, tumor location, and disease progression among low-risk prostate cancer patients.低危前列腺癌患者的种族、肿瘤位置和疾病进展。
Cancer Med. 2020 Mar;9(6):2235-2242. doi: 10.1002/cam4.2864. Epub 2020 Jan 21.
9
A multidimensional view of racial differences in access to prostate cancer care.获取前列腺癌护理方面种族差异的多维视角。
Cancer. 2017 Nov 15;123(22):4449-4457. doi: 10.1002/cncr.30894. Epub 2017 Jul 20.
10
Do African American men have lower survival from prostate cancer compared with White men? A meta-analysis.非裔美国男性的前列腺癌生存率是否低于白种男性?一项荟萃分析。
Am J Mens Health. 2010 Sep;4(3):189-206. doi: 10.1177/1557988309353934. Epub 2010 May 18.

引用本文的文献

1
Statistical Accuracy of Administratively Recorded Race/Ethnicity in the Military Health System and Race/Ethnicity Ascertained via Questionnaire.军事卫生系统中行政记录的种族/族裔信息以及通过问卷调查确定的种族/族裔信息的统计准确性。
J Racial Ethn Health Disparities. 2025 Mar 21. doi: 10.1007/s40615-025-02351-7.
2
Comparing Black and White Patients in Treatment of Advanced Prostate Cancer and Survival in an Equal Access Health System.在平等医疗体系中比较黑人和白人患者晚期前列腺癌的治疗及生存情况
J Racial Ethn Health Disparities. 2024 Oct 21. doi: 10.1007/s40615-024-02217-4.
3
General Obesity and Prostate Cancer in Relation to Abdominal Obesity and Ethnic Groups: A US Population-Based Cross-Sectional Study.
一般肥胖及前列腺癌与腹部肥胖和种族的关系:一项基于美国人群的横断面研究。
Res Rep Urol. 2024 Oct 9;16:235-244. doi: 10.2147/RRU.S489915. eCollection 2024.
4
MilCanEpi: Increased Capability for Cancer Care Research in the Department of Defense.MilCanEpi:提高国防部癌症护理研究能力。
JCO Clin Cancer Inform. 2023 Aug;7:e2300035. doi: 10.1200/CCI.23.00035.
5
Biomarkers of Aggressive Prostate Cancer at Diagnosis.诊断时侵袭性前列腺癌的生物标志物。
Int J Mol Sci. 2023 Jan 22;24(3):2185. doi: 10.3390/ijms24032185.
6
Evaluation of Social Determinants of Health and Prostate Cancer Outcomes Among Black and White Patients: A Systematic Review and Meta-analysis.评估黑人和白人患者的健康社会决定因素与前列腺癌结局:系统评价和荟萃分析。
JAMA Netw Open. 2023 Jan 3;6(1):e2250416. doi: 10.1001/jamanetworkopen.2022.50416.
7
Five-year survival of patients with late-stage prostate cancer: comparison of the Military Health System and the U.S. general population.晚期前列腺癌患者的 5 年生存率:军事卫生系统与美国普通人群的比较。
Br J Cancer. 2023 Apr;128(6):1070-1076. doi: 10.1038/s41416-022-02136-3. Epub 2023 Jan 6.
8
Survival analysis of the unsafe behaviors leading to urban expressway crashes.导致城市高速公路事故的不安全行为的生存分析。
PLoS One. 2022 Aug 26;17(8):e0267559. doi: 10.1371/journal.pone.0267559. eCollection 2022.
9
Race-specific prostate cancer outcomes in a cohort of military health care beneficiaries undergoing surgery: 1990-2017.特定种族的前列腺癌患者在接受手术的军队医疗受益人群中的结局:1990-2017 年。
Cancer Med. 2022 Nov;11(22):4354-4365. doi: 10.1002/cam4.4787. Epub 2022 May 31.
10
Race-specific prostate cancer outcomes in a cohort of low and favorable-intermediate risk patients who underwent external beam radiation therapy from 1990 to 2017.1990 年至 2017 年间接受外照射放疗的低危和中危患者队列中特定种族的前列腺癌结局。
Cancer Med. 2022 Dec;11(24):4756-4766. doi: 10.1002/cam4.4802. Epub 2022 May 26.